Renoprotective mechanisms of GLP1-RAs are not fully understood yet and present a challenge in developing studies that allow for combination therapies with drugs that can provide renoprotection in DKD without increasing the risk of adverse health outcomes. Here, GLP1R is linked to diabetic kidney disease.